Rosemary Lees obtained a BSc in Biological Sciences from Warwick University in 2004, and a DPhil in Zoology from Jesus College, Oxford in 2008. Her doctoral research focussed on developing transgenic strains of Aedes aegypti for vector control, then analysing their induced gene expression and phenotype and assessing the competitiveness of larvae and of adult males.
This interest in male mating biology developed during an FP7 Marie Curie fellowship looking at proxy indicators of mating success in Anopheles gambiae, and informed later work developing and overseeing Sterile Insect Technique projects for Aedes and Anopheles control in various parts of the world for the International Atomic Energy Agency.
Research
Research at LSTM focuses on the development and standardisation of bioassays to monitor insecticide resistance in mosquito vectors of disease and to test novel active ingredients as they are developed, for example those arising from IVCC. Work will also address the demand for novel behavioural assays to investigate behavioural, non-lethal effects of insecticides alongside the traditional methods for measuring mortality after exposure.
Research at LSTM, through her position as Methods Lead for Innovation to Impact (I2I), focuses on the development and standardisation of bioassays to monitor insecticide resistance in mosquito vectors of disease and to test novel active ingredients as they are developed, for example those arising from IVCC. There is a demand for novel behavioural assays to investigate novel, non-lethal effects of insecticides alongside the traditional methods for measuring mortality after exposure. Consensus building around standardised methodologies is important to increase the robustness of data and improve decision making for deployment of vector control tools. This was the subject of a recent special issue of Insects titled ‘Insecticides for Mosquito Control: Strengthening the Evidence Base ’.